D.B. Root & Company, LLC Biogen Inc. Transaction History

D.B. Root & Company, LLC

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2018 Nov 05, 2018	SELL	$293.51 - $383.83 $5,870 - $7,676	-20 Reduced 2.18%	897 $317,000
Q2 2018 Jul 25, 2018	SELL	$257.52 - $306.91 $203,440 - $242,458	-790 Reduced 46.28%	917 $266,000
Q1 2018 May 02, 2018	BUY	$260.13 - $367.91 $444,041 - $628,022	1,707 New	1,707 $467,000

1,015

126M

1.12M

1.43M

Ticker BIIB
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 144,000,992
Market Cap $20.3B
Description
Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...

Get notified when there are updates to the investment portfolio of D.B. Root & Company, LLC, based on Form 13F filings with the SEC.

Stay updated on D.B. Root & Company, LLC with notifications on news.